Vaxcyte, Inc. Common Stock

PCVX

...

PCVX: Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-XP, VAX-A1, and VAX-PG.

Show PCVX Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of PCVX by members of U.S. Congress

Politician	Type	Traded
Christopher L. Jacobs House / R	Sale $1,001 - $15,000	Dec. 12, 2022
Christopher L. Jacobs House / R	Purchase $1,001 - $15,000	Nov. 08, 2022

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by PCVX's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

Patent Title: Periodontitis vaccine and related compositions and methods of use Jul. 18, 2023
Patent Title: Periodontitis vaccine and related compositions and methods of use Nov. 17, 2020

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on PCVX's company Twitter account

WallStreetBets

Number of mentions of PCVX in WallStreetBets Daily Discussion

PCVX News

Recent insights relating to PCVX

CNBC Recommendations

Recent picks made for PCVX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PCVX

Corporate Flights

Flights by private jets registered to PCVX